Shares

27 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 13, 2024

BUY
$17.59 - $23.59 $52,963 - $71,029
3,011 Added 6.79%
47,331 $1.01 Million
Q4 2023

Feb 13, 2024

SELL
$13.91 - $21.32 $737 - $1,129
-53 Reduced 0.12%
44,320 $848,000
Q3 2023

Nov 13, 2023

BUY
$15.99 - $23.22 $15,238 - $22,128
953 Added 2.19%
44,373 $711,000
Q2 2023

Aug 04, 2023

SELL
$17.56 - $23.76 $1,580 - $2,138
-90 Reduced 0.21%
43,420 $1.01 Million
Q1 2023

May 12, 2023

BUY
$15.26 - $23.75 $2,762 - $4,298
181 Added 0.42%
43,510 $1.01 Million
Q4 2022

Feb 10, 2023

SELL
$14.51 - $20.99 $4,556 - $6,590
-314 Reduced 0.72%
43,329 $628,000
Q3 2022

Nov 14, 2022

BUY
$18.21 - $27.88 $9,013 - $13,800
495 Added 1.15%
43,643 $833,000
Q2 2022

Aug 12, 2022

SELL
$16.45 - $25.88 $38,558 - $60,662
-2,344 Reduced 5.15%
43,148 $784,000
Q1 2022

May 13, 2022

SELL
$22.67 - $28.01 $63,249 - $78,147
-2,790 Reduced 5.78%
45,492 $1.15 Million
Q4 2021

Feb 11, 2022

SELL
$24.13 - $32.63 $10,351 - $13,998
-429 Reduced 0.88%
48,282 $1.33 Million
Q3 2021

Nov 12, 2021

SELL
$29.97 - $36.66 $31,288 - $38,273
-1,044 Reduced 2.1%
48,711 $1.57 Million
Q2 2021

Aug 13, 2021

BUY
$25.39 - $32.61 $51,135 - $65,676
2,014 Added 4.22%
49,755 $1.52 Million
Q1 2021

May 07, 2021

SELL
$19.92 - $31.6 $11,434 - $18,138
-574 Reduced 1.19%
47,741 $1.45 Million
Q4 2020

Feb 12, 2021

SELL
$12.16 - $19.77 $14,008 - $22,775
-1,152 Reduced 2.33%
48,315 $955,000
Q3 2020

Nov 04, 2020

SELL
$11.25 - $14.75 $13,567 - $17,788
-1,206 Reduced 2.38%
49,467 $645,000
Q2 2020

Aug 12, 2020

BUY
$10.69 - $16.49 $15,414 - $23,778
1,442 Added 2.93%
50,673 $575,000
Q1 2020

May 04, 2020

SELL
$9.78 - $29.53 $23,794 - $71,846
-2,433 Reduced 4.71%
49,231 $704,000
Q4 2019

Feb 05, 2020

SELL
$20.93 - $35.1 $15,781 - $26,465
-754 Reduced 1.44%
51,664 $1.41 Million
Q3 2019

Nov 08, 2019

SELL
$22.08 - $47.08 $11,945 - $25,470
-541 Reduced 1.02%
52,418 $1.5 Million
Q2 2019

Aug 13, 2019

BUY
$22.67 - $35.0 $10,722 - $16,555
473 Added 0.9%
52,959 $1.47 Million
Q1 2019

May 06, 2019

SELL
$26.93 - $34.7 $67,567 - $87,062
-2,509 Reduced 4.56%
52,486 $1.74 Million
Q4 2018

Feb 13, 2019

BUY
$27.23 - $45.56 $61,294 - $102,555
2,251 Added 4.27%
54,995 $1.6 Million
Q3 2018

Nov 09, 2018

BUY
$37.57 - $50.34 $63,267 - $84,772
1,684 Added 3.3%
52,744 $2.43 Million
Q2 2018

Aug 08, 2018

BUY
$27.75 - $40.17 $258,602 - $374,344
9,319 Added 22.33%
51,060 $1.91 Million
Q1 2018

May 07, 2018

SELL
$28.83 - $41.01 $307,125 - $436,879
-10,653 Reduced 20.33%
41,741 $1.23 Million
Q4 2017

Feb 09, 2018

BUY
$28.45 - $37.14 $28,876 - $37,697
1,015 Added 1.98%
52,394 $1.8 Million
Q3 2017

Nov 09, 2017

BUY
$24.01 - $36.2 $1.23 Million - $1.86 Million
51,379
51,379 $1.86 Million

Others Institutions Holding MYGN

About MYRIAD GENETICS INC


  • Ticker MYGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 80,634,800
  • Market Cap $1.25B
  • Description
  • Myriad Genetics, Inc., a genetic testing and precision medicine company, develops and commercializes genetic tests in the United States and internationally. The company offers molecular diagnostic tests for use in oncology, and women's and mental health applications. It provides MyRisk Hereditary Cancer Test, a DNA sequencing test for assessing ...
More about MYGN
Track This Portfolio

Track American International Group, Inc. Portfolio

Follow American International Group, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of American International Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on American International Group, Inc. with notifications on news.